3Gyldenvang H, Mertz Bg, Ankerson L. Quality management-improving the clinical pathway for breast cancer patients[J]. Eur J Oncol Nurs, 2005, 9(1):79-82.
6Ushijima K. Treatment for recurrent ovarian cancer-at first relapse [J]. J Oncol, 2010,201 : 427-429.
7Morgan RJ, Alvarez RD, Armstrong DK, et al. NCCN Clinical Practice Guidelines in Oncology : ovarian cancer ( including fallo- pian tube cancer and primary peritoneal cancer). 2012.
8Halter P, du Bois A, Hahmann M, et al. Surgery in recurrent o-varian cancer: the Arbeitsgemeinschaft Gynaekologische Onkolo- gie (AGO) DESKTOP OVAR trial[ J]. Ann Surg Oncol, 2006, 13 (12) : 1702-1710.
9Bristow RE, Tomacruz RS, Armstrong DK, et al. Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. Journal of clinical on- eology : official journal of the American Society of Clinical [ J]. Oncol, 2002, 20 (5) : 1248-1259.
10Berek JS, Hacker NF, Lagasse LD, et al. Survival of patients following secondary cytoreductive surgery in ovarian cancer [ J ]. Obstet Gynecol, 1983,61 (2) :189-193.
